Thus, compounds that regulate the corepressor recruitment profile might be candidate agents for treating obesity and diabetes or useful biological tools to evaluate PPARγ-corepressor associations in biological models of obesity and diabetes. This evidence concerns the gene PPARG and obesity disorder.